Диссертация (Электростимуляция как альтернативный способ физическим тренировкам у пациентов с хронической обструктивной болезнью легких), страница 20

581–585.65. Berthelsen, P. Cardiovascular performance and oxyhemoglobin dissociationafter acetazolamide in metabolic alkalosis / P. Berthelsen // Intensive care medicine. –1982. – № 6 (8). – P. 269–274.66. Borg, G.A. Psychophysical bases of perceived exertion / G.A. Borg //Medicine and science in sports and exercise. – 1982. – № 5 (14).

– P. 377–381.67. Branconnier, M.P. Albuterol delivery during noninvasive ventilation / M.P.Branconnier, D.R. Hess // Respiratory care. – 2005. – № 12 (50). – P. 1649–1653.68. Branson, R.D. Is humidification always necessary during noninvasiveventilation in the hospital? / R.D. Branson, M.A. Gentile // Respiratory care.

– 2010. –№ 2 (55). – P. 209–216.69. Brill, S.E. Oxygen therapy in acute exacerbations of chronic obstructivepulmonary disease / S.E. Brill, J.A. Wedzicha // International journal of chronicobstructive pulmonary disease. – 2014. – № 9. – P. 1241–1252.70. British Thoracic Society Standards of Care Committee Non-invasiveventilation in acute respiratory failure // Thorax. – 2002. – № 3 (57). – P. 192–211.71. Brochard, L. Noninvasive ventilation for acute exacerbations of chronicobstructive pulmonary disease / L. Brochard [et al.] // The New England journal ofmedicine.

– 1995. – № 13 (333). – P. 817–822.72. Brulotte, C.A. Acute Exacerbations of Chronic Obstructive PulmonaryDisease in the Emergency Department / C.A. Brulotte, E.S. Lang // EmergencyMedicine Clinics of North America. – 2012. – № 2 (30). – P. 223–247.73. Bruno, C.M. Acid-base disorders in patients with chronic obstructivepulmonary disease: a pathophysiological review / C.M. Bruno, M.

Valenti // Journal ofbiomedicine & biotechnology. – 2012. – P. 915150.74. Carlucci, A. Noninvasive Versus Conventional Mechanical Ventilation / A.Carlucci [et al.] // American Journal of Respiratory and Critical Care Medicine. – 2001.– № 4 (163). – P. 874–880.11875. Carrillo, A. Noninvasive ventilation in acute hypercapnic respiratory failurecaused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease/ A. Carrillo [et al.] // American journal of respiratory and critical care medicine. –2012.

– № 12 (186). – P. 1279–1285.76. Carteaux, G. Patient-ventilator asynchrony during noninvasive ventilation: abench and clinical study / G. Carteaux [et al.] // Chest. – 2012. – № 2 (142). – P. 367–376.77. Casanova, C. Inspiratory-to-total lung capacity ratio predicts mortality inpatients with chronic obstructive pulmonary disease / C. Casanova [et al.] // Americanjournal of respiratory and critical care medicine. – 2005.

– № 6 (171). – P. 591–597.78. Celli, B.R. Predictors of mortality in COPD / B.R. Celli // RespiratoryMedicine. – 2010. – № 6 (104). – P. 773–779.79. Chakrabarti, B. Hyperglycaemia as a predictor of outcome during noninvasive ventilation in decompensated COPD / B. Chakrabarti [et al.] // Thorax. – 2009.– № 10 (64). – P.

857–862.80. Chandra, D. Outcomes of noninvasive ventilation for acute exacerbations ofchronic obstructive pulmonary disease in the United States, 1998–2008 / D. Chandra [etal.] // American journal of respiratory and critical care medicine. – 2012. – № 2 (185). –P. 152–159.81. Chapman, K.R. Epidemiology and costs of chronic obstructive pulmonarydisease / K.R. Chapman [et al.] // The European respiratory journal. – 2006. – № 1(27). – P. 188–207.82. Charlson, M.E. A new method of classifying prognostic comorbidity inlongitudinal studies: development and validation / M.E. Charlson [et al.] // Journal ofchronic diseases.

– 1987. – № 5 (40). – P. 373–383.83. Chatmongkolchart, S. In vitro evaluation of aerosol bronchodilator deliveryduring noninvasive positive pressure ventilation: effect of ventilator settings andnebulizer position / S. Chatmongkolchart [et al.] // Critical care medicine. – 2002. – №11 (30). – P. 2515–2519.84.

Chuchalin, A. Chronic respiratory diseases and risk factors in 12 regions of119the Russian Federation / A. Chuchalin [et al.] // International Journal of ChronicObstructive Pulmonary Disease. – 2014. – P. 963.85. Ciapponi, A. The Epidemiology and Burden of COPD in Latin America andthe Caribbean: Systematic Review and Meta-Analysis / A. Ciapponi [et al.] // COPD:Journal of Chronic Obstructive Pulmonary Disease.

– 2013. – № 11(3). – P. 339–350.86. Confalonieri, M. A chart of failure risk for noninvasive ventilation in patientswith COPD exacerbation / M. Confalonieri [et al.] // European Respiratory Journal. –2005. – № 2 (25). – P. 348–355.87. Conti, G. Noninvasive vs. conventional mechanical ventilation in patientswith chronic obstructive pulmonary disease after failure of medical treatment in theward: a randomized trial / G. Conti [et al.] // Intensive care medicine. – 2002.

– № 12(28). – P. 1701–1707.88. Crompton, G.K. The need to improve inhalation technique in Europe: Areport from the Aerosol Drug Management Improvement Team / G.K. Crompton [et al.]// Respiratory Medicine. – 2006. – Т. 100, № 9. – P. 1479–1494.89. Cushen, B. Pilot study to assess bronchodilator response during an acuteexacerbation of copd using a vibrating mesh nebuliser versus jet nebuliser forbronchodilator delivery / B. Cushen [et al.] // Thorax.

– 2016. – № Suppl 3 (71). – P.A251 LP–A251.90. Cydulka, R.K. Effects of combined treatment with glycopyrrolate andalbuterol in acute exacerbation of chronic obstructive pulmonary disease / R.K.Cydulka, C.L. Emerman // Annals of emergency medicine. – 1995. – № 4 (25). – P.470–473.91.

Deakins, K. A comparison of intrapulmonary percussive ventilation andconventional chest physiotherapy for the treatment of atelectasis in the pediatric patient/ K. Deakins, R.L. Chatburn // Respiratory care. – 2002. – № 10 (47). – P. 1162–1167.92. DeVries, R. Validation of the breathlessness, cough and sputum scale topredict COPD exacerbation / R. DeVries, D. Kriebel, S. Sama // Npj Primary CareRespiratory Medicine. – 2016.

– № 26. – P. 16083.93. Dhand, R. Aerosol therapy in patients receiving noninvasive positive pressure120ventilation / R. Dhand // Journal of aerosol medicine and pulmonary drug delivery. –2012. – № 2 (25). – P. 63–78.94. Dhand, R. How Should Aerosols Be Delivered During Invasive MechanicalVentilation? / R. Dhand // Respiratory care. – 2017. – № 10 (62). – P. 1343–1367.95. Dhand, R.How best to deliver aerosol medications to mechanicallyventilated patients / R. Dhand, V.P Guntur // Clinics in chest medicine. – 2008. – № 2(29). – P.

277–296.96. Díaz, G.G. Noninvasive positive-pressure ventilation to treat hypercapniccoma secondary to respiratory failure / G.G. Díaz [et al.] // Chest. – 2005. – № 3 (127).– P. 952–960.97. DuBose, T.D. Clinical Approach to Patients with Acid-Base Disorders / T.D.DuBose // Medical Clinics of North America. – 1983. – № 4 (67). – P. 799–813.98.

Dubosky, M.N. Vibrating Mesh Nebulizer Compared With Metered-DoseInhaler in Mechanically Ventilated Subjects / M.N. Dubosky [et al.] // Respiratory Care.– 2017. – № 4 (62). – P. 391–395.99. Dunne, R.B. Comparison of bronchodilator administration with vibratingmesh nebulizer and standard jet nebulizer in the emergency department / R.B. Dunne, S.Shortt // The American journal of emergency medicine. – 2018.

– № 4 (36). – P. 641–646.100. Echevarria, C. Validation of the DECAF score to predict hospital mortalityin acute exacerbations of COPD / C. Echevarria [et al.] // Thorax. – 2016. – № 2 (71). –P. 133–140.101. Ehrmann, S. Aerosol therapy during mechanical ventilation: an internationalsurvey / S. Ehrmann [et al.] // Intensive Care Medicine. – 2013. – № 6 (39). – P. 1048–1056.102. Ehrmann, S. Aerosol therapy in intensive and intermediate care units:prospective observation of 2808 critically ill patients / S. Ehrmann [et al.] // IntensiveCare Medicine.

– 2016. – № 2 (42). – P. 192–201.103. Ehrmann, S. Vibrating Mesh Nebulisers – Can Greater Drug Delivery to theAirways and Lungs Improve Respiratory Outcomes? / S. Ehrmann // European121Respiratory & Pulmonary Diseases. – 2018. – № 1 (4). – P. 33.104. Eisner, M.D. An Official American Thoracic Society Public PolicyStatement: Novel Risk Factors and the Global Burden of Chronic ObstructivePulmonary Disease / M.D.

Eisner [et al.] // American Journal of Respiratory andCritical Care Medicine. – 2010. – № 5 (182). – P. 693–718.105. Esquinas, A.M. Aerosol therapy during non-invasive mechanical ventilation:Review of key technical factors and clinical implications / A.M. Esquinas [et al.] //Canadian Journal of Respiratory Therapy. – 2013. – № 1 (49). – P.

11–18.106. Faisy, C. Effectiveness of acetazolamide for reversal of metabolic alkalosisin weaning COPD patients from mechanical ventilation / C. Faisy [et al.] // Intensivecare medicine. – 2010. – № 5 (36). – P. 859–863.107. Faisy, C. Effect of Acet azolamide vs Placebo on Duration of InvasiveMechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease /C. Faisy [et al.] // JAMA.

– 2016. – № 5 (315). – P. 480.108. Fall, P.J. A stepwise approach to acid-base disorders / P.J. Fall //Postgraduate Medicine. – 2000. – № 3 (107). – P. 249–263.109. Fernandez, A. Comparison of one versus two bronchodilators in ventilatedCOPD patients / A. Fernandez [et al.] // Intensive Care Medicine. – 1994. – № 3 (20). –P. 199–202.110. Fontana, V. Effect of acetazolamide on post-NIV metabolic alkalosis inacute exacerbated COPD patients / V.

Fontana[et al.] // European review for medicaland pharmacological sciences. – 2016. – № 1 (20). – P. 37–43.111. Galindo-Filho, V.C. Radioaerosol Pulmonary Deposition Using Mesh andJet Nebulizers During Noninvasive Ventilation in Healthy Subjects / V.C. GalindoFilho [et al.] // Respiratory Care. – 2015. – № 9 (60). – P. 1238–1246.112.